Global Transdermal Patch Drug Delivery System Market Size, Status and Forecast 2019-2025

Published On: Nov 2019

Format: PDF

Publisher: QY Research

Pages: 126

Report ID: 68093

This report focuses on the global Transdermal Patch Drug Delivery System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transdermal Patch Drug Delivery System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Hisamitsu Pharmaceutical
Novartis
ProSolus
Tapemark
Tesa Labtec
NITTO DENKO CORPORATION
Noven Pharmaceuticals
LTS Lohmann Therapie-Systeme
Medherant
Corium
Antares Pharma
Syntropharma
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical

Market segment by Type, the product can be split into
Shunt Way
Intercellular Lipid Structure Pathway
Trans-cellular Pathway

Market segment by Application, split into
Hospital
Clinic
Home Care
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Transdermal Patch Drug Delivery System status, future forecast, growth opportunity, key market and key players.
To present the Transdermal Patch Drug Delivery System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Transdermal Patch Drug Delivery System are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type (2014-2025)
1.4.2 Shunt Way
1.4.3 Intercellular Lipid Structure Pathway
1.4.4 Trans-cellular Pathway
1.5 Market by Application
1.5.1 Global Transdermal Patch Drug Delivery System Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Transdermal Patch Drug Delivery System Market Size
2.2 Transdermal Patch Drug Delivery System Growth Trends by Regions
2.2.1 Transdermal Patch Drug Delivery System Market Size by Regions (2019-2025)
2.2.2 Transdermal Patch Drug Delivery System Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Transdermal Patch Drug Delivery System Market Size by by Players
3.1.1 Global Transdermal Patch Drug Delivery System Revenue by by Players (2014-2019)
3.1.2 Global Transdermal Patch Drug Delivery System Revenue Market Share by by Players (2014-2019)
3.1.3 Global Transdermal Patch Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.2 Transdermal Patch Drug Delivery System Key Players Head office and Area Served
3.3 Key Players Transdermal Patch Drug Delivery System Product/Solution/Service
3.4 Date of Enter into Transdermal Patch Drug Delivery System Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Transdermal Patch Drug Delivery System Market Size by Type (2014-2019)
4.2 Global Transdermal Patch Drug Delivery System Market Size by Application (2014-2019)

5 North America
5.1 North America Transdermal Patch Drug Delivery System Market Size (2014-2019)
5.2 Transdermal Patch Drug Delivery System Key Players in North America
5.3 North America Transdermal Patch Drug Delivery System Market Size by Type
5.4 North America Transdermal Patch Drug Delivery System Market Size by Application

6 Europe
6.1 Europe Transdermal Patch Drug Delivery System Market Size (2014-2019)
6.2 Transdermal Patch Drug Delivery System Key Players in Europe
6.3 Europe Transdermal Patch Drug Delivery System Market Size by Type
6.4 Europe Transdermal Patch Drug Delivery System Market Size by Application

7 China
7.1 China Transdermal Patch Drug Delivery System Market Size (2014-2019)
7.2 Transdermal Patch Drug Delivery System Key Players in China
7.3 China Transdermal Patch Drug Delivery System Market Size by Type
7.4 China Transdermal Patch Drug Delivery System Market Size by Application

8 Japan
8.1 Japan Transdermal Patch Drug Delivery System Market Size (2014-2019)
8.2 Transdermal Patch Drug Delivery System Key Players in Japan
8.3 Japan Transdermal Patch Drug Delivery System Market Size by Type
8.4 Japan Transdermal Patch Drug Delivery System Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Transdermal Patch Drug Delivery System Market Size (2014-2019)
9.2 Transdermal Patch Drug Delivery System Key Players in Southeast Asia
9.3 Southeast Asia Transdermal Patch Drug Delivery System Market Size by Type
9.4 Southeast Asia Transdermal Patch Drug Delivery System Market Size by Application

10 India
10.1 India Transdermal Patch Drug Delivery System Market Size (2014-2019)
10.2 Transdermal Patch Drug Delivery System Key Players in India
10.3 India Transdermal Patch Drug Delivery System Market Size by Type
10.4 India Transdermal Patch Drug Delivery System Market Size by Application

11 Central & South America
11.1 Central & South America Transdermal Patch Drug Delivery System Market Size (2014-2019)
11.2 Transdermal Patch Drug Delivery System Key Players in Central & South America
11.3 Central & South America Transdermal Patch Drug Delivery System Market Size by Type
11.4 Central & South America Transdermal Patch Drug Delivery System Market Size by Application

12 International Players Profiles
12.1 Hisamitsu Pharmaceutical
12.1.1 Hisamitsu Pharmaceutical Company Details
12.1.2 Company Description and Business Overview
12.1.3 Transdermal Patch Drug Delivery System Introduction
12.1.4 Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2014-2019))
12.1.5 Hisamitsu Pharmaceutical Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Transdermal Patch Drug Delivery System Introduction
12.2.4 Novartis Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 ProSolus
12.3.1 ProSolus Company Details
12.3.2 Company Description and Business Overview
12.3.3 Transdermal Patch Drug Delivery System Introduction
12.3.4 ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.3.5 ProSolus Recent Development
12.4 Tapemark
12.4.1 Tapemark Company Details
12.4.2 Company Description and Business Overview
12.4.3 Transdermal Patch Drug Delivery System Introduction
12.4.4 Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.4.5 Tapemark Recent Development
12.5 Tesa Labtec
12.5.1 Tesa Labtec Company Details
12.5.2 Company Description and Business Overview
12.5.3 Transdermal Patch Drug Delivery System Introduction
12.5.4 Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.5.5 Tesa Labtec Recent Development
12.6 NITTO DENKO CORPORATION
12.6.1 NITTO DENKO CORPORATION Company Details
12.6.2 Company Description and Business Overview
12.6.3 Transdermal Patch Drug Delivery System Introduction
12.6.4 NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.6.5 NITTO DENKO CORPORATION Recent Development
12.7 Noven Pharmaceuticals
12.7.1 Noven Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Transdermal Patch Drug Delivery System Introduction
12.7.4 Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.7.5 Noven Pharmaceuticals Recent Development
12.8 LTS Lohmann Therapie-Systeme
12.8.1 LTS Lohmann Therapie-Systeme Company Details
12.8.2 Company Description and Business Overview
12.8.3 Transdermal Patch Drug Delivery System Introduction
12.8.4 LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.8.5 LTS Lohmann Therapie-Systeme Recent Development
12.9 Medherant
12.9.1 Medherant Company Details
12.9.2 Company Description and Business Overview
12.9.3 Transdermal Patch Drug Delivery System Introduction
12.9.4 Medherant Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.9.5 Medherant Recent Development
12.10 Corium
12.10.1 Corium Company Details
12.10.2 Company Description and Business Overview
12.10.3 Transdermal Patch Drug Delivery System Introduction
12.10.4 Corium Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
12.10.5 Corium Recent Development
12.11 Antares Pharma
12.12 Syntropharma
12.13 Teikoku Pharma
12.14 Mylan
12.15 Actavis
12.16 Mundipharma
12.17 Henan Lingrui Pharmaceutical
12.18 Changzhou Siyao
12.19 Rfl Pharmaceutical

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details